| Scrip Code | 543635 |
|---|---|
| NSE Symbol | PPLPHARMA |
| MSEI Symbol | NOTLISTED |
| ISIN | INE0DK501011 |
| Name of company | PIRAMAL PHARMA LIMITED |
| Type of company | Main Board |
| Class of security | Equity |
| Date of start of financial year | 01-04-2025 |
| Date of end of financial year | 31-03-2026 |
| Date of board meeting when results were approved | 28-04-2026 |
| Date on which prior intimation of the meeting for considering financial results was informed to the exchange | |
| Description of presentation currency | INR |
| Level of rounding used in financial results | Lakhs |
| Reporting Type | Quarterly |
| Reporting Quarter | Fourth quarter |
| Nature of report standalone or consolidated | Consolidated |
| Whether results are audited or unaudited for the quarter ended | Unaudited |
| Whether results are audited or unaudited for the Year to date for current period ended/year ended | Audited |
| Segment Reporting | Single segment |
| Description of single segment | Pharmaceuticals |
| Start date and time of board meeting | 28-04-2026 17:45:00 |
| End date and time of board meeting | 28-04-2026 19:30:00 |
| Whether cash flow statement is applicable on company | Yes |
| Type of cash flow statement | Cash Flow Indirect |
| Declaration of unmodified opinion or statement on impact of audit qualification | Declaration of unmodified opinion |
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
|---|---|---|---|
| A | Date of start of reporting period | 01-01-2026 | 01-04-2025 |
| B | Date of end of reporting period | 31-03-2026 | 31-03-2026 |
| C | Whether results are audited or unaudited | Unaudited | Audited |
| D | Nature of report standalone or consolidated | Consolidated | Consolidated |
| 1 | Income | ||
| Revenue from operations | 2,75,177.00 | 8,86,908.00 | |
| Other income | 4,606.00 | 21,330.00 | |
| Total income | 2,79,783.00 | 9,08,238.00 | |
| 2 | Expenses | ||
| (a) | Cost of materials consumed | 48,259.00 | 1,99,585.00 |
| (b) | Purchases of stock-in-trade | 33,603.00 | 1,43,053.00 |
| (c) | Changes in inventories of finished goods, work-in-progress and stock-in-trade | 23,705.00 | (18,784.00) |
| (d) | Employee benefit expense | 58,602.00 | 2,41,592.00 |
| (e) | Finance costs | 8,299.00 | 34,080.00 |
| (f) | Depreciation, depletion and amortisation expense | 21,838.00 | 83,124.00 |
| (f) | Other Expenses | ||
| 1 | Other Expenses (Net) | 64,957.00 | 2,29,300.00 |
| Total other expenses | 64,957.00 | 2,29,300.00 | |
| Total expenses | 2,59,263.00 | 9,11,950.00 | |
| 3 | Total profit before exceptional items and tax | 20,520.00 | (3,712.00) |
| 4 | Exceptional items | (17,577.00) | (19,614.00) |
| 5 | Total profit before tax | 2,943.00 | (23,326.00) |
| 6 | Tax expense | ||
| 7 | Current tax | 2,570.00 | 16,211.00 |
| 8 | Deferred tax | 2,613.00 | (1,223.00) |
| 9 | Total tax expenses | 5,183.00 | 14,988.00 |
| 10 | Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement | 0.00 | 0.00 |
| 11 | Net Profit Loss for the period from continuing operations | (2,240.00) | (38,314.00) |
| 12 | Profit (loss) from discontinued operations before tax | 0.00 | 0.00 |
| 13 | Tax expense of discontinued operations | 0.00 | 0.00 |
| 14 | Net profit (loss) from discontinued operation after tax | 0.00 | 0.00 |
| 15 | Share of profit (loss) of associates and joint ventures accounted for using equity method | 1,358.00 | 5,720.00 |
| 16 | Total profit (loss) for period | (882.00) | (32,594.00) |
| 17 | Other comprehensive income net of taxes | 16,328.00 | 33,838.00 |
| 18 | Total Comprehensive Income for the period | 15,446.00 | 1,244.00 |
| 19 | Total profit or loss, attributable to | ||
| Profit or loss, attributable to owners of parent | (882.00) | (32,594.00) | |
| Total profit or loss, attributable to non-controlling interests | 0.00 | 0.00 | |
| 20 | Total Comprehensive income for the period attributable to | ||
| Comprehensive income for the period attributable to owners of parent | 16,328.00 | 33,837.00 | |
| Total comprehensive income for the period attributable to owners of parent non-controlling interests | 0.00 | 0.00 | |
| 21 | Details of equity share capital | ||
| Paid-up equity share capital | 1,32,716.00 | 1,32,716.00 | |
| Face value of equity share capital | 10 | 10 | |
| 27 | Details of debt securities | ||
| 22 | Reserves excluding revaluation reserve | 6,83,546.00 | |
| 23 | Earnings per share | ||
| i | Earnings per equity share for continuing operations | ||
| Basic earnings (loss) per share from continuing operations | -0.07 | -2.46 | |
| Diluted earnings (loss) per share from continuing operations | -0.07 | -2.46 | |
| ii | Earnings per equity share for discontinued operations | ||
| Basic earnings (loss) per share from discontinued operations | 0 | 0 | |
| Diluted earnings (loss) per share from discontinued operations | 0 | 0 | |
| ii | Earnings per equity share | ||
| Basic earnings (loss) per share from continuing and discontinued operations | -0.07 | -2.46 | |
| Diluted earnings (loss) per share from continuing and discontinued operations | -0.07 | -2.46 | |
| 24 | Debt equity ratio | ||
| 25 | Debt service coverage ratio | ||
| 26 | Interest service coverage ratio | ||
| 27 | Disclosure of notes on financial results | Textual Information(1) | |
| Textual Information(1) | Refer to the audited consolidated financial results submitted on April 28, 2026, to the Stock Exchange |
|---|
| Debt equity ratio | |
|---|---|
| Debt service coverage ratio | |
| Interest service coverage ratio |
| Particulars | Year ended (dd-mm-yyyy) | |
|---|---|---|
| Date of start of reporting period | 01-04-2025 | |
| Date of end of reporting period | 31-03-2026 | |
| Whether results are audited or unaudited | Audited | |
| Nature of report standalone or consolidated | Consolidated | |
| Assets | ||
| 1 | Non-current assets | |
| Property, plant and equipment | 4,45,071.00 | |
| Capital work-in-progress | 79,917.00 | |
| Investment property | 0.00 | |
| Goodwill | 1,25,743.00 | |
| Other intangible assets | 2,58,385.00 | |
| Intangible assets under development | 30,062.00 | |
| Biological assets other than bearer plants | 0.00 | |
| Investments accounted for using equity method | 24,424.00 | |
| Non-current financial assets | ||
| Non-current investments | 6,077.00 | |
| Trade receivables, non-current | 0.00 | |
| Loans, non-current | 0.00 | |
| Other non-current financial assets | ||
| 1 | Others | 4,033.00 |
| Total of other non-current financial assets | 4,033.00 | |
| Total non-current financial assets | 10,110.00 | |
| Deferred tax assets (net) | 51,473.00 | |
| Other non-current assets | ||
| 1 | Others | 52,153.00 |
| Total of other non-current assets | 52,153.00 | |
| Total non-current assets | 10,77,338.00 | |
| 2 | Current assets | |
| Inventories | 3,06,444.00 | |
| Current financial asset | ||
| Current investments | 13,178.00 | |
| Trade receivables, current | 2,15,767.00 | |
| Cash and cash equivalents | 1,19,988.00 | |
| Bank balance other than cash and cash equivalents | 2,376.00 | |
| Loans, current | 0.00 | |
| Other current financial assets | ||
| Total of other current financial assets | 6,546.00 | |
| Total current financial assets | 3,57,855.00 | |
| Current tax assets (net) | 0.00 | |
| Other current assets | ||
| 1 | Others | 54,867.00 |
| Total of other current assets | 54,867.00 | |
| Total current assets | 7,19,166.00 | |
| 3 | Non-current assets classified as held for sale | |
| 4 | Regulatory deferral account debit balances and related deferred tax Assets | |
| Total assets | 17,96,504.00 | |
| Equity and liabilities | ||
| 1 | Equity | |
| Equity attributable to owners of parent | ||
| Equity share capital | 1,32,716.00 | |
| Other equity | 6,83,546.00 | |
| Total equity attributable to owners of parent | 8,16,262.00 | |
| Non controlling interest | 0.00 | |
| Total equity | 8,16,262.00 | |
| 2 | Liabilities | |
| Non-current liabilities | ||
| Non-current financial liabilities | ||
| Borrowings, non-current | 4,29,997.00 | |
| Trade payables, non-current | ||
| (A) Total outstanding dues of micro enterprises and small enterprises | 0.00 | |
| (B) Total outstanding dues of creditors other than micro enterprises and small enterprises | 0.00 | |
| Total Trade payable | 0.00 | |
| Other non-current financial liabilities | ||
| 1 | Others | 13,543.00 |
| Total of other non-current financial liabilities | 13,543.00 | |
| Total non-current financial liabilities | 4,43,540.00 | |
| Provisions, non-current | 9,431.00 | |
| Deferred tax liabilities (net) | 35,818.00 | |
| Deferred government grants, Non-current | 0.00 | |
| Other non-current liabilities | ||
| 1 | Others | 15,625.00 |
| Total of other non-current liabilities | 15,625.00 | |
| Total non-current liabilities | 5,04,414.00 | |
| Current liabilities | ||
| Current financial liabilities | ||
| Borrowings, current | 1,19,551.00 | |
| Trade payables, current | ||
| (A) Total outstanding dues of micro enterprises and small enterprises | 10,157.00 | |
| (B) Total outstanding dues of creditors other than micro enterprises and small enterprises | 2,37,754.00 | |
| Total Trade payable | 2,47,911.00 | |
| Other current financial liabilities | ||
| 1 | Others | 43,769.00 |
| Total of other current financial liabilities | 43,769.00 | |
| Total current financial liabilities | 4,11,231.00 | |
| Other current liabilities | 59,321.00 | |
| 1 | Others | 59,321.00 |
| Total of other current liabilities | 59,321.00 | |
| Provisions, current | 4,221.00 | |
| Current tax liabilities (Net) | 1,055.00 | |
| Deferred government grants, Current | ||
| Total current liabilities | 4,75,828.00 | |
| 3 | Liabilities directly associated with assets in disposal group classified as held for sale | |
| 4 | Regulatory deferral account credit balances and related deferred tax liability | |
| Total liabilities | 9,80,242.00 | |
| Total equity and liabilites | 17,96,504.00 | |
| Disclosure of notes on assets and liabilities | ||
| Particulars | 3 months/ 6 month ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |||||
|---|---|---|---|---|---|---|---|
| Date of start of reporting period | 01-01-2026 | 01-04-2025 | |||||
| Date of end of reporting period | 31-03-2026 | 31-03-2026 | |||||
| Whether results are audited or unaudited | Unaudited | Audited | |||||
| Nature of report standalone or consolidated | Consolidated | Consolidated | |||||
| 1 | Segment Revenue (Income) | ||||||
| (net sale/income from each segment should be disclosed) | |||||||
| Total Segment Revenue | |||||||
| Less: Inter segment revenue | |||||||
| Revenue from operations | |||||||
| 2 | Segment Result | ||||||
| Profit (+) / Loss (-) before tax and interest from each segment | |||||||
| Total Profit before tax | |||||||
| i. Finance cost | |||||||
| ii. Other Unallocable Expenditure net off Unallocable income | |||||||
| Profit before tax | |||||||
| 3 | (Segment Asset - Segment Liabilities) | ||||||
| Segment Asset | |||||||
| Total Segment Asset | |||||||
| Un-allocable Assets | null | null | |||||
| Net Segment Asset | null | null | |||||
| 4 | Segment Liabilities | ||||||
| Segment Liabilities | |||||||
| Total Segment Liabilities | |||||||
| Un-allocable Liabilities | null | null | |||||
| Net Segment Liabilities | null | null | |||||
| Disclosure of notes on segments | |||||||
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
|---|---|---|---|
| A | Date of start of reporting period | 01-01-2026 | 01-04-2025 |
| B | Date of end of reporting period | 31-03-2026 | 31-03-2026 |
| C | Whether results are audited or unaudited | Unaudited | Audited |
| D | Nature of report standalone or consolidated | Consolidated | Consolidated |
| Other comprehensive income [Abstract] | |||
| 1 | Amount of items that will not be reclassified to profit and loss | ||
| 1 | Remeasurement of Post Employment Benefit Plans | (1,019.00) | (1,250.00) |
| Total Amount of items that will not be reclassified to profit and loss | (1,019.00) | (1,250.00) | |
| 2 | Income tax relating to items that will not be reclassified to profit or loss | (256.00) | (315.00) |
| 3 | Amount of items that will be reclassified to profit and loss | ||
| 1 | Deferred gains / (losses) on cash flow hedge | (306.00) | (3,495.00) |
| 2 | Exchange differences on translation of foreign operations | 19,280.00 | 42,588.00 |
| 3 | Share of other comprehensive income/ (expense) of associates accounted for using the equity method | (13.00) | (13.00) |
| Total Amount of items that will be reclassified to profit and loss | 18,961.00 | 39,080.00 | |
| 4 | Income tax relating to items that will be reclassified to profit or loss | 1,870.00 | 4,307.00 |
| 5 | Total Other comprehensive income | 16,328.00 | 33,838.00 |
| Particulars | Year ended (dd-mm-yyyy) | |||||
|---|---|---|---|---|---|---|
| A | Date of start of reporting period | 01-04-2025 | ||||
| B | Date of end of reporting period | 31-03-2026 | ||||
| C | Whether results are audited or unaudited | Audited | ||||
| D | Nature of report standalone or consolidated | Consolidated | ||||
| Statement of cash flows | ||||||
| Cash flows from used in operating activities | ||||||
| Profit before tax | (23,326.00) | |||||
| Adjustments for reconcile profit (loss) | ||||||
| Adjustments for finance costs | 34,080.00 | |||||
| Adjustments for decrease (increase) in inventories | (79,809.00) | |||||
| Adjustments for decrease (increase) in trade receivables, current | 21,719.00 | |||||
| Adjustments for decrease (increase) in trade receivables, non-current | 0.00 | |||||
| Adjustments for decrease (increase) in other current assets | 662.00 | |||||
| Adjustments for decrease (increase) in other non-current assets | 1,380.00 | |||||
| Adjustments for other financial assets, non-current | (1,963.00) | |||||
| Adjustments for other financial assets, current | (2,268.00) | |||||
| Adjustments for other bank balances | 0.00 | |||||
| Adjustments for increase (decrease) in trade payables, current | 77,802.00 | |||||
| Adjustments for increase (decrease) in trade payables, non-current | 0.00 | |||||
| Adjustments for increase (decrease) in other current liabilities | 31,442.00 | |||||
| Adjustments for increase (decrease) in other non-current liabilities | (786.00) | |||||
| Adjustments for depreciation and amortisation expense | 83,124.00 | |||||
| Adjustments for impairment loss reversal of impairment loss recognised in profit or loss | 0.00 | |||||
| Adjustments for provisions, current | (64.00) | |||||
| Adjustments for provisions, non-current | 3,303.00 | |||||
| Adjustments for other financial liabilities, current | 1,238.00 | |||||
| Adjustments for other financial liabilities, non-current | 0.00 | |||||
| Adjustments for unrealised foreign exchange losses gains | 18,428.00 | |||||
| Adjustments for dividend income | 0.00 | |||||
| Adjustments for interest income | 517.00 | |||||
| Adjustments for share-based payments | 4,172.00 | |||||
| Adjustments for fair value losses (gains) | (1,224.00) | |||||
| Adjustments for undistributed profits of associates | 0.00 | |||||
| Other adjustments for which cash effects are investing or financing cash flow | 0.00 | |||||
| Other adjustments to reconcile profit (loss) | 0.00 | |||||
| Other adjustments for non-cash items | 18,881.00 | |||||
| Share of profit and loss from partnership firm or association of persons or limited liability partnerships | 0.00 | |||||
| Total adjustments for reconcile profit (loss) | 2,09,600.00 | |||||
| Net cash flows from (used in) operations | 1,86,274.00 | |||||
| Dividends received | 0.00 | |||||
| Interest paid | 0.00 | |||||
| Interest received | 0.00 | |||||
| Income taxes paid (refund) | 21,015.00 | |||||
| Other inflows (outflows) of cash | 0.00 | |||||
| Net cash flows from (used in) operating activities | 1,65,259.00 | |||||
| Cash flows from used in investing activities | ||||||
| Cash flows from losing control of subsidiaries or other businesses | 0.00 | |||||
| Cash flows used in obtaining control of subsidiaries or other businesses | 0.00 | |||||
| Other cash receipts from sales of equity or debt instruments of other entities | 88,794.00 | |||||
| Other cash payments to acquire equity or debt instruments of other entities | 99,168.00 | |||||
| Other cash receipts from sales of interests in joint ventures | 0.00 | |||||
| Other cash payments to acquire interests in joint ventures | 0.00 | |||||
| Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships | 0.00 | |||||
| Cash payment for investment in partnership firm or association of persons or limited liability partnerships | 0.00 | |||||
| Proceeds from sales of property, plant and equipment | 1,344.00 | |||||
| Purchase of property, plant and equipment | 89,002.00 | |||||
| Proceeds from sales of investment property | 0.00 | |||||
| Purchase of investment property | 0.00 | |||||
| Proceeds from sales of intangible assets | 0.00 | |||||
| Purchase of intangible assets | 0.00 | |||||
| Proceeds from sales of intangible assets under development | 0.00 | |||||
| Purchase of intangible assets under development | 0.00 | |||||
| Proceeds from sales of goodwill | 0.00 | |||||
| Purchase of goodwill | 0.00 | |||||
| Proceeds from biological assets other than bearer plants | 0.00 | |||||
| Purchase of biological assets other than bearer plants | 0.00 | |||||
| Proceeds from government grants | 0.00 | |||||
| Proceeds from sales of other long-term assets | 224.00 | |||||
| Purchase of other long-term assets | 0.00 | |||||
| Cash advances and loans made to other parties | 0.00 | |||||
| Cash receipts from repayment of advances and loans made to other parties | 0.00 | |||||
| Cash payments for future contracts, forward contracts, option contracts and swap contracts | 0.00 | |||||
| Cash receipts from future contracts, forward contracts, option contracts and swap contracts | 0.00 | |||||
| Dividends received | 3,773.00 | |||||
| Interest received | 559.00 | |||||
| Income taxes paid (refund) | 0.00 | |||||
| Other inflows (outflows) of cash | 10,873.00 | |||||
| Net cash flows from (used in) investing activities | (82,603.00) | |||||
| Cash flows from used in financing activities | ||||||
| Proceeds from changes in ownership interests in subsidiaries | 0.00 | |||||
| Payments from changes in ownership interests in subsidiaries | 0.00 | |||||
| Proceeds from issuing shares | 0.00 | |||||
| Proceeds from issuing other equity instruments | 0.00 | |||||
| Payments to acquire or redeem entity's shares | 0.00 | |||||
| Payments of other equity instruments | 0.00 | |||||
| Proceeds from exercise of stock options | 281.00 | |||||
| Proceeds from issuing debentures notes bonds etc | 0.00 | |||||
| Proceeds from borrowings | 1,88,740.00 | |||||
| Repayments of borrowings | 1,56,699.00 | |||||
| Payments of lease liabilities | 4,729.00 | |||||
| Dividends paid | 1,855.00 | |||||
| Interest paid | 29,635.00 | |||||
| Income taxes paid (refund) | 0.00 | |||||
| Other inflows (outflows) of cash | 0.00 | |||||
| Net cash flows from (used in) financing activities | (3,897.00) | |||||
| Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes | 78,759.00 | |||||
| Effect of exchange rate changes on cash and cash equivalents | ||||||
| Effect of exchange rate changes on cash and cash equivalents | 635.00 | |||||
| Net increase (decrease) in cash and cash equivalents | 79,394.00 | |||||
| Cash and cash equivalents cash flow statement at beginning of period | 18,232.00 | |||||
| Cash and cash equivalents cash flow statement at end of period | 97,626.00 | |||||
| Whether results are audited or unaudited | Audited |
|---|---|
| Declaration of unmodified opinion or statement on impact of audit qualification | Declaration of unmodified opinion |
| Auditor's opinion | |
| Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results | Yes |
| Sr No. | Audit firm's name | Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI | Certificate valid upto | ||
| 1 | Suresh Surana & Associates LLP | Yes | 31-03-2028 | ||
|---|---|---|---|---|---|